NCT07192601

Brief Summary

Electronic (e-)cigarettes are the most used nicotine product among U.S. youth. Hispanic/Latino (H/L) youth are at greater risk for e-cigarette use, yet few evidence-based cessation programs exist for youth, and even fewer are tailored to H/L youth. The current work will develop and pilot an e-cigarette cessation intervention for H/L high school youth, using focus groups with the target population and input from a community advisory board (CAB). The intervention will be tested with 120 H/L high school students who use e-cigarettes to assess its feasibility and promise for reducing use.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
19mo left

Started May 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
May 2024Apr 2028

Study Start

First participant enrolled

May 1, 2024

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

September 5, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

September 25, 2025

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2028

Last Updated

September 30, 2026

Status Verified

September 1, 2026

Enrollment Period

3.7 years

First QC Date

September 5, 2025

Last Update Submit

September 26, 2026

Conditions

Keywords

adolescentsvaping cessationcognitive behavioral therapy

Outcome Measures

Primary Outcomes (5)

  • E-Cigarette Assessment for Youth-Revised checklist

    This measure assesses the timing, brand, flavoring, quantity, and frequency of current and past e-cigarette use.

    Baseline assessment: data will be reported on past 1-month and 1-year e-cigarette use Each weekly intervention session: data will be reported on past 1-week e-cigarette use Follow-up assessment: data will be reported on past 1-month e-cigarette use

  • Salivary cotinine samples

    To biochemically verify self-reports of abstinence, saliva samples will be obtained using NicAlert cotinine test strips.

    Saliva cotinine samples that can detect past-week nicotine use will be obtained at Baseline (Week 0), at the end of treatment (Week 6), and at the 3-month follow-up after treatment completion (Week 18).

  • Patient-Reported Outcomes Measurement Information System Nicotine Dependence Bank for E-Cigarettes

    The Patient-Reported Outcomes Measurement Information System Nicotine Dependence Bank for E-Cigarettes (PROMIS-E) is a 4-item measure (each item scored on a 5-point Likert scale) that assesses nicotine dependence. Values range from 0 to 16 with higher scores representing worse outcomes.

    Baseline assessment: data will be reported on past 1-month symptoms Each weekly intervention session: data will be reported on past 1-week symptoms Follow-up assessment: data will be reported on past 1-month symptoms

  • Questionnaire of Vaping Craving

    The Questionnaire of Vaping Craving (QVC) is a 10-item measure (each item scored on a 7-point Likert scale) that assesses vaping craving. Values range from 10 to 70 with higher scores representing worse outcomes.

    Baseline assessment: data will be reported on past 1-month craving Each weekly intervention session: data will be reported on past 1-week craving Follow-up assessment: data will be reported on past 1-month craving

  • Wisconsin Smoking Nicotine Withdrawal Scale

    The Wisconsin Smoking Nicotine Withdrawal Scale (WSWS) is a 28-item measure (each item scored on a 5-point Likert scale) that assesses nicotine withdrawal symptoms. Values range from 0 to 112 with higher scores representing worse outcomes.

    Baseline assessment: data will be reported on past 1-week withdrawal symptoms Each weekly intervention session: data will be reported on past 1-week withdrawal symptoms Follow-up assessment: data will be reported on past 1-week withdrawal symptoms

Secondary Outcomes (8)

  • Timeline Followback questionnaire

    Baseline assessment: data will be reported on past 1-month and past 1-year substance use Each weekly intervention session: data will be reported on past 1-week substance use Follow-up assessment: data will be reported on past 1-month substance use

  • Adolescent E-Cigarette Consequences Questionnaire

    Baseline assessment: data will be reported on past 1-week expectancies Follow-up assessment: data will be reported on past 1-week expectancies

  • PROMIS Emotional Distress Depression and Anxiety Pediatric Item Bank

    Baseline assessment: data will be reported on past 2-week symptoms experienced Follow-up assessment: data will be reported on past 2-week symptoms experienced

  • Parental Monitoring, Child Disclosure, and Relationship Quality

    Baseline assessment: data will be reported on past 1-week perceptions Follow-up assessment: data will be reported on past 1-week perceptions

  • Resistance to Peer Influence

    Baseline assessment: data will be reported on past 1-week perceptions Follow-up assessment: data will be reported on past 1-week perceptions

  • +3 more secondary outcomes

Study Arms (1)

Single Arm

OTHER

See Intervention Section

Behavioral: E-cigarette Cessation Manual

Interventions

The intervention is grounded in an empirically supported psychosocial smoking cessation program (i.e., Cognitive Behavior Therapy \[CBT\]; Vinci, 2020), as well as a manualized CBT e-cigarette intervention for adolescents and young adults (Kong et al., 2017; Kong et al., 2021). The structure and content of the manual were further informed by themes identified through focus groups. The newly developed BReATHE Program will consist of six 60-minute group sessions. "Building Knowledge for Change" focuses on nicotine vaping psychoeducation. "Recognizing the Triangle" introduces the cognitive triangle. "Anticipating Triggers" offers tools to cope with internal and external triggers to vape. "Tranquil Minds" offers relaxation techniques to manage negative emotions. "Healthy Communication" teaches clients more effective ways to communicate. "Educate Others" consists of reviewing skills and planning for the graduation ceremony where youth will teach family members what they learned.

Single Arm

Eligibility Criteria

Age14 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Enrolled in high school or 14-18 years old
  • Fluent in English
  • Identify as being of Hispanic/Latino origin
  • Report current use of e-cigarettes (i.e., used ≥ 4x in the past month or at least 1x per week in the past month)

You may not qualify if:

  • Having a history of severe psychiatric conditions (e.g., bipolar disorder, schizophrenia, psychosis, or schizoaffective disorder)
  • Currently enrolled in or planning on enrolling in another e-cigarette and/or tobacco cessation intervention
  • Having potential difficulties comprehending study procedures (e.g., not able to speak/write in English, have a severe learning disability or other neurodevelopmental disorders)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FIU Center for Children and Families

Miami, Florida, 33199, United States

Location

Related Publications (26)

  • Miech, R. A., Johnston, L. D., Patrick, M. E., O'Malley, P. M., & Bachman, J. G. (2023). Monitoring the Future national survey results on drug use, 1975-2023: Secondary school students. Monitoring the Future Monograph Series. Ann Arbor, MI: Institute for Social Research, University of Michigan. Available at https://monitoringthefuture.org/results/annual-reports/

    BACKGROUND
  • Pinedo M, Villatoro AP. The role of perceived treatment need in explaining racial/ethnic disparities in the use of substance abuse treatment services. J Subst Abuse Treat. 2020 Nov;118:108105. doi: 10.1016/j.jsat.2020.108105. Epub 2020 Aug 13.

    PMID: 32839050BACKGROUND
  • Tackett AP, Keller-Hamilton B, Hebert ET, Smith CE, Wallace SW, Stevens EM, Johnson AL, Wagener TL. Adolescent Susceptibility to E-Cigarettes: An Update From the 2018 National Youth Tobacco Survey. Am J Health Promot. 2021 May;35(4):551-558. doi: 10.1177/0890117120971121. Epub 2020 Nov 10.

    PMID: 33167676BACKGROUND
  • Valencia CV, Dove M, Tong EK. Factors Associated With Receipt of Smoking Cessation Advice and Assistance by Health Professionals Among Latino and Non-Latino White Smokers With Medicaid Insurance in California. JAMA Netw Open. 2022 Jan 4;5(1):e2144207. doi: 10.1001/jamanetworkopen.2021.44207.

    PMID: 35044467BACKGROUND
  • Pinedo M, Zemore S, Beltran-Giron J, Gilbert P, Castro Y. Women's Barriers to Specialty Substance Abuse Treatment: A Qualitative Exploration of Racial/Ethnic Differences. J Immigr Minor Health. 2020 Aug;22(4):653-660. doi: 10.1007/s10903-019-00933-2.

    PMID: 31531756BACKGROUND
  • Lopez-Quintero C, Crum RM, Neumark YD. Racial/ethnic disparities in report of physician-provided smoking cessation advice: analysis of the 2000 National Health Interview Survey. Am J Public Health. 2006 Dec;96(12):2235-9. doi: 10.2105/AJPH.2005.071035. Epub 2006 Jun 29.

    PMID: 16809587BACKGROUND
  • Cokkinides VE, Halpern MT, Barbeau EM, Ward E, Thun MJ. Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey. Am J Prev Med. 2008 May;34(5):404-12. doi: 10.1016/j.amepre.2008.02.003.

    PMID: 18407007BACKGROUND
  • Unger JB, Falcon A. E-cigarette use among Hispanics: Reducing risk or recruiting new tobacco users? Addict Behav. 2022 Feb;125:107149. doi: 10.1016/j.addbeh.2021.107149. Epub 2021 Oct 12.

    PMID: 34678711BACKGROUND
  • Bastiaens L, Galus J. The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure as a Screening Tool. Psychiatr Q. 2018 Mar;89(1):111-115. doi: 10.1007/s11126-017-9518-7.

    PMID: 28523431BACKGROUND
  • Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol. 2009 Jan 15;169(2):236-48. doi: 10.1093/aje/kwn301. Epub 2008 Nov 19.

    PMID: 19019851BACKGROUND
  • Bold K, Kong G, Cavallo D, Davis D, Jackson A, Krishnan-Sarin S. School-based E-cigarette cessation programs: What do youth want? Addict Behav. 2022 Feb;125:107167. doi: 10.1016/j.addbeh.2021.107167. Epub 2021 Oct 28.

    PMID: 34753093BACKGROUND
  • Cavallo DA, Cooney JL, Duhig AM, Smith AE, Liss TB, McFetridge AK, Babuscio T, Nich C, Carroll KM, Rounsaville BJ, Krishnan-Sarin S. Combining cognitive behavioral therapy with contingency management for smoking cessation in adolescent smokers: a preliminary comparison of two different CBT formats. Am J Addict. 2007 Nov-Dec;16(6):468-74. doi: 10.1080/10550490701641173.

    PMID: 18058412BACKGROUND
  • Cristello JV, Sutherland MT, Trucco EM. A preliminary validation of the adolescent e-cigarette consequences questionnaire. Drug Alcohol Depend. 2020 Aug 1;213:108118. doi: 10.1016/j.drugalcdep.2020.108118. Epub 2020 Jun 12.

    PMID: 32559666BACKGROUND
  • Dowd AN, Motschman CA, Tiffany ST. Development and Validation of the Questionnaire of Vaping Craving. Nicotine Tob Res. 2019 Jan 1;21(1):63-70. doi: 10.1093/ntr/nty046.

    PMID: 29546379BACKGROUND
  • Hartmann SA, Cristello JV, Manresa O, Trucco EM. The e-cigarette assessment for youth-Revised (EAsY-R): Preliminary results of a pilot study of measure refinement via cognitive interviewing. J Res Adolesc. 2024 Sep;34(3):845-856. doi: 10.1111/jora.12957. Epub 2024 Apr 28.

    PMID: 38679807BACKGROUND
  • Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003 Feb;5(1):13-25.

    PMID: 12745503BACKGROUND
  • Kong G, Bold KW, Cavallo DA, Davis DR, Jackson A, Krishnan-Sarin S. Informing the development of adolescent e-cigarette cessation interventions: A qualitative study. Addict Behav. 2021 Mar;114:106720. doi: 10.1016/j.addbeh.2020.106720. Epub 2020 Oct 21.

    PMID: 33162230BACKGROUND
  • Kong G, Goldberg AL, Dallery J, Krishnan-Sarin S. An open-label pilot study of an intervention using mobile phones to deliver contingency management of tobacco abstinence to high school students. Exp Clin Psychopharmacol. 2017 Oct;25(5):333-337. doi: 10.1037/pha0000151.

    PMID: 29048181BACKGROUND
  • Krishnan-Sarin S, Cavallo DA, Cooney JL, Schepis TS, Kong G, Liss TB, Liss AK, McMahon TJ, Nich C, Babuscio T, Rounsaville BJ, Carroll KM. An exploratory randomized controlled trial of a novel high-school-based smoking cessation intervention for adolescent smokers using abstinence-contingent incentives and cognitive behavioral therapy. Drug Alcohol Depend. 2013 Sep 1;132(1-2):346-51. doi: 10.1016/j.drugalcdep.2013.03.002. Epub 2013 Mar 22.

    PMID: 23523130BACKGROUND
  • Morean ME, Krishnan-Sarin S, S O'Malley S. Assessing nicotine dependence in adolescent E-cigarette users: The 4-item Patient-Reported Outcomes Measurement Information System (PROMIS) Nicotine Dependence Item Bank for electronic cigarettes. Drug Alcohol Depend. 2018 Jul 1;188:60-63. doi: 10.1016/j.drugalcdep.2018.03.029. Epub 2018 Apr 26.

    PMID: 29753155BACKGROUND
  • Sobell LC, Cunningham JA, Sobell MB. Recovery from alcohol problems with and without treatment: prevalence in two population surveys. Am J Public Health. 1996 Jul;86(7):966-72. doi: 10.2105/ajph.86.7.966.

    PMID: 8669520BACKGROUND
  • Stattin H, Kerr M. Parental monitoring: a reinterpretation. Child Dev. 2000 Jul-Aug;71(4):1072-85. doi: 10.1111/1467-8624.00210.

    PMID: 11016567BACKGROUND
  • Steinberg L, Monahan KC. Age differences in resistance to peer influence. Dev Psychol. 2007 Nov;43(6):1531-1543. doi: 10.1037/0012-1649.43.6.1531.

    PMID: 18020830BACKGROUND
  • Vinci C. Cognitive Behavioral and Mindfulness-Based Interventions for Smoking Cessation: a Review of the Recent Literature. Curr Oncol Rep. 2020 May 16;22(6):58. doi: 10.1007/s11912-020-00915-w.

    PMID: 32415381BACKGROUND
  • Welsch SK, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol. 1999 Nov;7(4):354-61. doi: 10.1037//1064-1297.7.4.354.

    PMID: 10609970BACKGROUND
  • Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA. Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess. 1990 Winter;55(3-4):610-7. doi: 10.1080/00223891.1990.9674095.

    PMID: 2280326BACKGROUND

MeSH Terms

Conditions

Tobacco Use Disorder

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: As this is a pilot study, all participants (N=120) will be enrolled in the same vaping cessation program, which will be grounded in an empirically supported psychosocial smoking cessation program (i.e., Cognitive Behavioral Therapy, CBT) that has been found to be effective in both adults, as well as adolescents.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Psychology

Study Record Dates

First Submitted

September 5, 2025

First Posted

September 25, 2025

Study Start

May 1, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

April 30, 2028

Last Updated

September 30, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations